OptimizeRx (OPRX) Non-Current Debt (2023 - 2026)

OptimizeRx's Non-Current Debt history runs 4 years deep, the most recent figure standing at $21.3 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 26.88% year-over-year to $21.3 million; the TTM figure through Mar 2026 stood at $21.3 million (down 26.88% YoY), while the FY2025 annual figure was $21.4 million, down 30.49% from the prior year.
• Non-Current Debt came in at $21.3 million for Q1 2026 at OptimizeRx, roughly flat from $21.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $34.2 million in Q4 2023 to a low of $21.3 million in Q1 2026.
• A 4-year average of $28.5 million and a median of $30.0 million in 2024 frame the typical range for Non-Current Debt.
• On a YoY basis, Non-Current Debt climbed as much as 9.94% in 2025 and fell as far as 30.49% in 2025.
• OptimizeRx's Non-Current Debt stood at $34.2 million in 2023, then dropped by 9.98% to $30.8 million in 2024, then sank by 30.49% to $21.4 million in 2025, then fell by 0.36% to $21.3 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $21.3 million, $21.4 million, and $24.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison